...
search icon
sprc-img

Scisparc Ltd, Common Stock

SPRC

NAQ

$0.4987

-$0.03

(-5.67%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$5.40M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
189.00K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.04
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.2 L
$6.78 H
$0.4987

About Scisparc Ltd, Common Stock

SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameSPRCSectorS&P500
1-Week Return0.52%-0.03%1.53%
1-Month Return-34.15%4.56%4.75%
3-Month Return115.98%1.29%2.77%
6-Month Return54.88%-3.54%12.18%
1-Year Return-86.22%1.59%22.34%
3-Year Return-99.62%13.55%38.91%
5-Year Return-99.57%40.85%80.7%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue498.00K550.00K1.07M1.35M2.88M[{"date":"2019-12-31","value":17.3,"profit":true},{"date":"2020-12-31","value":19.1,"profit":true},{"date":"2021-12-31","value":37.13,"profit":true},{"date":"2022-12-31","value":46.79,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue179.00K164.00K33.00K322.00K683.00K[{"date":"2019-12-31","value":26.21,"profit":true},{"date":"2020-12-31","value":24.01,"profit":true},{"date":"2021-12-31","value":4.83,"profit":true},{"date":"2022-12-31","value":47.14,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit319.00K386.00K1.04M1.02M2.20M[{"date":"2019-12-31","value":14.53,"profit":true},{"date":"2020-12-31","value":17.58,"profit":true},{"date":"2021-12-31","value":47.18,"profit":true},{"date":"2022-12-31","value":46.68,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin64.06%70.18%96.91%76.10%76.28%[{"date":"2019-12-31","value":66.1,"profit":true},{"date":"2020-12-31","value":72.42,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":78.52,"profit":true},{"date":"2023-12-31","value":78.71,"profit":true}]
Operating Expenses4.11M2.55M5.77M8.40M7.97M[{"date":"2019-12-31","value":48.88,"profit":true},{"date":"2020-12-31","value":30.35,"profit":true},{"date":"2021-12-31","value":68.63,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":94.81,"profit":true}]
Operating Income(4.11M)(3.29M)(5.77M)(7.38M)(5.77M)[{"date":"2019-12-31","value":-410800000,"profit":false},{"date":"2020-12-31","value":-329300000,"profit":false},{"date":"2021-12-31","value":-576800000,"profit":false},{"date":"2022-12-31","value":-738000000,"profit":false},{"date":"2023-12-31","value":-577300000,"profit":false}]
Total Non-Operating Income/Expense(744.00K)(472.00K)(39.00K)3.56M(97.00K)[{"date":"2019-12-31","value":-20.89,"profit":false},{"date":"2020-12-31","value":-13.25,"profit":false},{"date":"2021-12-31","value":-1.09,"profit":false},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":-2.72,"profit":false}]
Pre-Tax Income(4.48M)(3.54M)(5.79M)(2.58M)(5.86M)[{"date":"2019-12-31","value":-447900000,"profit":false},{"date":"2020-12-31","value":-353500000,"profit":false},{"date":"2021-12-31","value":-578900000,"profit":false},{"date":"2022-12-31","value":-257800000,"profit":false},{"date":"2023-12-31","value":-586100000,"profit":false}]
Income Taxes883.00K(28.00K)12.00K14.00K22.00K[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-3.17,"profit":false},{"date":"2021-12-31","value":1.36,"profit":true},{"date":"2022-12-31","value":1.59,"profit":true},{"date":"2023-12-31","value":2.49,"profit":true}]
Income After Taxes(5.36M)(3.51M)(5.80M)(2.59M)(5.88M)[{"date":"2019-12-31","value":-536200000,"profit":false},{"date":"2020-12-31","value":-350700000,"profit":false},{"date":"2021-12-31","value":-580100000,"profit":false},{"date":"2022-12-31","value":-259200000,"profit":false},{"date":"2023-12-31","value":-588300000,"profit":false}]
Income From Continuous Operations(4.48M)(3.54M)(5.79M)(2.59M)(5.88M)[{"date":"2019-12-31","value":-447900000,"profit":false},{"date":"2020-12-31","value":-353500000,"profit":false},{"date":"2021-12-31","value":-578900000,"profit":false},{"date":"2022-12-31","value":-259200000,"profit":false},{"date":"2023-12-31","value":-588300000,"profit":false}]
Income From Discontinued Operations(207.00K)----[{"date":"2019-12-31","value":-20700000,"profit":false},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(5.36M)(3.51M)(5.80M)(2.59M)(5.12M)[{"date":"2019-12-31","value":-536200000,"profit":false},{"date":"2020-12-31","value":-350700000,"profit":false},{"date":"2021-12-31","value":-580100000,"profit":false},{"date":"2022-12-31","value":-259200000,"profit":false},{"date":"2023-12-31","value":-512200000,"profit":false}]
EPS (Diluted)(88.80)(17.71)---[{"date":"2019-12-31","value":-8880.08,"profit":false},{"date":"2020-12-31","value":-1771,"profit":false},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

SPRC
Cash Ratio 3.23
Current Ratio 4.10
Quick Ratio 3.63

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SPRC
ROA (LTM) -38.85%
ROE (LTM) -85.91%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SPRC
Debt Ratio Lower is generally better. Negative is bad. 0.14
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.68

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SPRC
Trailing PE NM
Forward PE NM
P/S (TTM) 3.28
P/B 0.83
Price/FCF NM
EV/R 1.85
EV/Ebitda 1.21

FAQs

What is Scisparc Ltd share price today?

Scisparc Ltd (SPRC) share price today is $0.4987

Can Indians buy Scisparc Ltd shares?

Yes, Indians can buy shares of Scisparc Ltd (SPRC) on Vested. To buy Scisparc Ltd from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SPRC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Scisparc Ltd be purchased?

Yes, you can purchase fractional shares of Scisparc Ltd (SPRC) via the Vested app. You can start investing in Scisparc Ltd (SPRC) with a minimum investment of $1.

How to invest in Scisparc Ltd shares from India?

You can invest in shares of Scisparc Ltd (SPRC) via Vested in three simple steps:

  • Click on Sign Up or Invest in SPRC stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Scisparc Ltd shares
What is Scisparc Ltd 52-week high and low stock price?

The 52-week high price of Scisparc Ltd (SPRC) is $6.78. The 52-week low price of Scisparc Ltd (SPRC) is $0.2.

What is Scisparc Ltd price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Scisparc Ltd (SPRC) is 0.83

What is the Market Cap of Scisparc Ltd?

The market capitalization of Scisparc Ltd (SPRC) is $5.40M

What is Scisparc Ltd’s stock symbol?

The stock symbol (or ticker) of Scisparc Ltd is SPRC

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top